NCT04329364

Brief Summary

Haemorrhoids or piles are the most common colorectal condition in the local population. Patients often present with bleeding with bowel movement or anal discomfort, both of which causes significant anxiety and stress. For symptomatic sizeable piles, the treatment of choice still remains the conventional open excision (COH). However, this technique carries with it a significant risk of bleeding and pain immediately after the operation, leading to some period of discomfort for the patients. The laser haemorrhoidoplasty procedure (LAH) has been shown in preliminary studies to have less pain, and less complications compared to COH. This study aims to directly compare these two techniques in a local Asian population. The investigators would be conducting a single-centre RCT simultaneously comparing the conventional open Milligan-Morgan haemorrhoidectomy (COH) and the laser haemorrhoidoplasty procedure (LAH) for the treatment of symptomatic grade ll-lV haemorrhoids. Primary outcomes will be post-operative pain while secondary outcomes include post-operative bleeding, readmission and/or reoperations, haemorrhoid-related quality of life (QoL) results and recurrence of symptoms up to a year post procedure

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
128

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Oct 2020

Longer than P75 for phase_2

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 19, 2020

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 1, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

October 1, 2020

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

April 22, 2024

Status Verified

April 1, 2024

Enrollment Period

4.3 years

First QC Date

March 19, 2020

Last Update Submit

April 19, 2024

Conditions

Keywords

haemorrhoidlaserhaemorrhoidectomy

Outcome Measures

Primary Outcomes (1)

  • Pain scores

    Daily visual analogue pain scale in the first 10 days after surgery. A score of 10 being the worst pain experienced and 1 being no pain experienced.

    10 days from op

Secondary Outcomes (5)

  • Operative duration

    during operation

  • Post-op bleeding

    10 days from operation

  • readmission

    3 months

  • recurrence

    1 year post operation

  • Quality of Life measures

    10 days, 1 month, 3 months and 1 year post operation

Study Arms (2)

Laser Haemorrhoidoplasty (LAH)

EXPERIMENTAL

treatment that we would like to study

Combination Product: Laser Haemorrhoidoplasty (LAH)

Conventional Open Haemorrhoidectomy (COH)

ACTIVE COMPARATOR

gold standard treatment as comparator

Procedure: Open milligan-morgan conventional haemorrhoidectomy

Interventions

Using a laser diode to cause coagulative necrosis to the haemorrhoidal cushion

Laser Haemorrhoidoplasty (LAH)

conventional excisional haemorrhoidectomy

Conventional Open Haemorrhoidectomy (COH)

Eligibility Criteria

Age21 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • between 21-90 years old
  • presents with symptomatic haemorrhoids as evident from clinical assessment
  • never had any haemorrhoid-related operations performed on them before
  • fit for general anaesthesia
  • able to give informed consent
  • willing to be randomized
  • willing to fill in post-operative questionnaires and be compliant to follow up

You may not qualify if:

  • Are pregnant
  • Are prisoners
  • Intellectually, mentally or emotionally deemed not able to provide an informed consent and/or are unable to fill up the post-procedure questionnaires/VAS score
  • Have had previous haemorrhoid procedural treatment before (except Rubber Band Ligation)
  • Declined endoscopic evaluation
  • Are on anti-coagulation
  • Have history of thrombophilia
  • Are on steroids
  • Have haemorrhoids which are incidentally found on endoscopy/clinical examination but are asymptomatic from it

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sengkang General Hospital

Singapore, 544886, Singapore

RECRUITING

Related Publications (1)

  • Koh FH, Foo FJ, Ho L, Sivarajah SS, Tan WJ, Chew MH. Study Protocol for the Use of Conventional Open Haemorrhoidectomy versus Laser Haemorrhoidoplasty in the Treatment of Symptomatic Haemorrhoids: A Randomized Controlled Trial. Eur Surg Res. 2020;61(6):201-208. doi: 10.1159/000513844. Epub 2021 Feb 25.

MeSH Terms

Conditions

Hemorrhoids

Condition Hierarchy (Ancestors)

Rectal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Allocation is provided through calling the study administrator at time of Examination under Anaesthesia. Thus, the participant is blinded to the procedure. There will also be no cross-over from one study arm to another. An independent research administrator, not part of the randomisation process, will also contact the patient 3 months and 1 year after the procedure as mentioned above.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The investigators would be conducting a single-centre RCT simultaneously comparing the conventional open Milligan-Morgan haemorrhoidectomy (COH) and the laser haemorrhoidoplasty procedure (LAH) for the treatment of symptomatic grade ll-lV haemorrhoids.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Consultant, Principal Investigator

Study Record Dates

First Submitted

March 19, 2020

First Posted

April 1, 2020

Study Start

October 1, 2020

Primary Completion

December 31, 2024

Study Completion

June 30, 2025

Last Updated

April 22, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

country's personal data protection Act restrictions clearance

Locations